Scientists track superbug genes in pneumonia patients
NCT ID NCT06566898
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at the types of germs and their resistance genes in 800 people with pneumonia. Researchers will compare severe and mild cases to understand which microbes and resistance patterns are most common. The goal is to improve how doctors diagnose and treat pneumonia, especially when antibiotics may not work.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors choose better antibiotics for pneumonia, reducing treatment failure and slowing resistance.
- What could go wrong
- This is an observational study, not testing a treatment. Results may not directly change practice and depend on accurate sequencing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIMICROBIAL RESISTANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mei Kang
RECRUITINGShanghai, Shanghai Municipality, 200080, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Breathing technique may outperform spirometry for smog pneumonia recovery
- A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
- Can a smart oxygen device shorten hospital stays for pneumonia?
- Could everyday supplements shield your lungs?
- Can a simple inhaled combo keep pneumonia patients off ventilators?